Skip to content
OpenCapital
Get started

Zevra Therapeutics, Inc. ZVRA Market capitalization

Market capitalization at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$10.86B-19.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$1B+18.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$673.38M+93.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$835.73M+89.2%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.78B+300%

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Enterprise value$678.78M+30.8%
P/E6.2×—
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity0×-1.5×
Current ratio4.9×+1.9×

Where this comes from

Computed from the period-end share price: $547.19M.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s market capitalization?
Zevra Therapeutics, Inc. (ZVRA) reported market capitalization of $547.19M in Q1 2026.
How has Zevra Therapeutics, Inc.'s market capitalization changed year-over-year?
Zevra Therapeutics, Inc.'s market capitalization increased by 35.0% year-over-year, from $405.33M to $547.19M.
What is the long-term trend for Zevra Therapeutics, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s market capitalization has grown at a 59.0% compound annual growth rate (CAGR), from $49.56M to $504.43M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.